[1] ANDERSON R A, FEATHERGILL K, DIAO X, et al. Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases[J]. Androl, 2000,21:862-875.
[2] BABA M, NAKAJIMA M, SCHOLS D, et al. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro[J]. Antiviral Res, 1988,9(6):335-343.
[3] ZHU J, AURELIAN L. AP-1 cis-response elements are involved in basal expression and Vmw 110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase(ICP10)[J].Virology, 1997,231(2):301-312.
[4] KOELLE D M, COREY L. Recent progress in herpes simplex virus immunobiology and vaccine research[J]. Clin Microbiol Rev, 2003,16:96-113.
[5] GILLGRASS A E, ASHKAR A A, ROSENTHAL K L, et al. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2[J]. J Virol,2003,77:9845-9851.
[6] LEKSTROM-HIMES J A, WANG K, PESNICAK L, et al. The comparative biology of latent herpes simplex virus type 1 and type 2 infections:latency-associated transcript promoter activity and expression in vitro and in infected mice[J].J Neurovirol,1998,4(1):27-37.
[7] 丁洁,周静,袁榴娣.果蝇S2细胞中高表达荧光素酶重组质粒的构建及活性测定[J].东南大学学报:医学版,2006,25(6):403-406.
[8] EGORINA E M, SOVERSHAEV M A, OSTERUD B. In cell western assay: a new approach to visualize tissue factor in human monocytes[J].J Thromb Haemost, 2006,4(3):614-620.
[9] MCLEAN C S, ERTURK M, JENNINGS R, et al.Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type-2 using a genetically disabled HSV-1[J]. Infect Dis, 1994,170:1100-1109.
[10] 刘庆芝,姚吉龙,都红蕾,等.全反式维甲酸对裸鼠子宫内膜癌治疗作用的实验研究[J].东南大学学报:医学版,2011,30(2):278-282.
[11] ZHU J, HLADIK F, WOODWARD A, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition[J].Nature Medicine, 2009,15:886-892. |